Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 249

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitors

Open access
Wang, Runming, Lai, Tsz-Pui, Gao, Peng, Zhang, Hongmin, Ho, Pak-Leung, Woo, Patrick Chiu-Yat, Ma, Guixing, Kao, Richard Yi-Tsun, Li, Hongyan, Sun, Hongzhe·2018·Nature Communications

Abstract

Drug-resistant superbugs pose a huge threat to human health. Infections by Enterobacteriaceae producing metallo-β-lactamases (MBLs), e.g., New Delhi metallo-β-lactamase 1 (NDM-1) are very difficult to treat. Development of effective MBL inhibitors to revive the efficacy of existing antibiotics is highly desirable. However, such inhibitors are not clinically available till now. Here we show that an anti-Helicobacter pylori drug, colloidal bismuth subcitrate (CBS), and related Bi(III) compounds irreversibly inhibit different types of MBLs via the mechanism, with one Bi(III) displacing two Zn(II) ions as revealed by X-ray crystallography, leading to the release of Zn(II) cofactors. CBS restores meropenem (MER) efficacy against MBL-positive bacteria in vitro, and in mice infection model, importantly, also slows down the development of higher-level resistance in NDM-1-positive bacteria. This study demonstrates a high potential of Bi(III) compounds as the first broad-spectrum B1 MBL inhibitors to treat MBL-positive bacterial infection in conjunction with existing carbapenems.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-018-02828-6

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 249

Metadata

Authors
Wang, R., Lai, T.-P., Gao, P., Zhang, H., Ho, P.-L., Woo, P. C.-Y., Ma, G., Kao, R. Y.-T., Li, H., & Sun, H.
Venue
Nature Communications
Published
2018-01-30
Volume
9
Issue
1
Pages
439-439
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2791003574
Cited by
249
References
4
FWCI
8.35
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitors. https://app.cochat.ai/papers/10.1038/s41467-018-02828-6
The paper
Wang, R., Lai, T.-P., Gao, P., Zhang, H., Ho, P.-L., Woo, P. C.-Y., Ma, G., Kao, R. Y.-T., Li, H., & Sun, H. (2018). Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitors. Nature Communications. https://doi.org/10.1038/s41467-018-02828-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.